Drugmaker Liquidia rallies on United Therapeutics settlement
14/10/2026 09:42
BUZZ-Drugmaker Liquidia rallies on United Therapeutics settlement ** Drugmaker Liquidia's LQDA.O shares up 46.21% at $39.20 premarket
** Co says it settles all six pending lawsuits with United Therapeutics UTHR.O, ensuring uninterrupted access to YUTREPIA, a drug used to treat patients with a form of pulmonary hypertension
** Co to pay a net $380.7 mln in instalments through 2027 to resolve the litigation
** Stock down more than 22% YTD, as of last close
(Reporting by Jayasree Prabhu)
Recent news on Liquidia
See all newsUS STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing